Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AOC2 | O75106 | 20/20 | 1.00 |
| ▸ | MAOB | P27338 | 3/20 | 0.75 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23358648 | 1.00 | AOC2 (1.00) | AOC2MAOB | |
| SCHEMBL23358639 | 1.00 | AOC2 (1.00) | AOC2MAOB | |
| SCHEMBL23358638 | 1.00 | AOC2 (1.00) | AOC2MAOB | |
| SCHEMBL23358536 | 0.97 | AOC2 (1.00) | AOC2MAOB | |
| SCHEMBL23358481 | 0.97 | AOC2 (1.00) | AOC2MAOB | |
| SCHEMBL23358477 | 0.97 | AOC2 (1.00) | AOC2MAOB | |
| SCHEMBL23358482 | 0.97 | AOC2 (1.00) | AOC2MAOB | |
| SCHEMBL23358571 | 0.86 | AOC2 (1.00) | AOC2MAOB | |
| SCHEMBL23358567 | 0.86 | AOC2 (1.00) | AOC2MAOB | |
| SCHEMBL23358550 | 0.85 | AOC2 (1.00) | AOC2MAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11472769-B2 | SSAO inhibitors and use thereof | ECCOGENE (SHANGHAI) CO., LTD. (CN) | 2022-10-18 | — | — | US | claimed |
| US-11964942-B2 | SSAO inhibitors and use thereof | ECCOGENE (SHANGHAI) CO., LTD. (CN) | 2024-04-23 | — | — | US | disclosed |
| US-20230026801-A1 | SSAO INHIBITORS AND USE THEREOF | ECCOGENE INC. | 2023-01-26 | — | — | US | disclosed |
| US-20210147360-A1 | SSAO INHIBITORS AND USE THEREOF | ECCOGENE INC. | 2021-05-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11964942-B2 | SSAO inhibitors and use thereof | SSB, HAO1, SORD | AOC2 39/4885MAOB 21/4885 |
| US-20230026801-A1 | SSAO INHIBITORS AND USE THEREOF | SSB, HAO1, SORD | AOC2 39/4885MAOB 21/4885 |
| US-11472769-B2 | SSAO inhibitors and use thereof | SSB, HAO1, SORD | AOC2 39/4885MAOB 21/4885 |
| US-20210147360-A1 | SSAO INHIBITORS AND USE THEREOF | SSB, HAO1, SORD | AOC2 39/4885MAOB 21/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.